Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial inner membrane (MIM) lipid environment is a specialized phospholipid bilayer essential for cellular energy metabolism. It is uniquely characterized by a high concentration of cardiolipin, a phospholipid that anchors electron transport chain (ETC) complexes and maintains the structural integrity of mitochondrial cristae (Paradies et al., 2014, PMID: 24530770). This environment is critical for the formation of respiratory supercomplexes, which ensure efficient electron transfer and minimize the production of reactive oxygen species (ROS). In many pathological states, including heart failure and Barth syndrome, the MIM lipid environment is compromised by cardiolipin loss or oxidative damage, leading to mitochondrial decay (Szeto, 2014, PMID: 24431002). Therapeutic agents like elamipretide target this environment by binding to cardiolipin, thereby stabilizing the membrane and restoring mitochondrial function (Birk et al., 2013, PMID: 23413032). Consequently, protecting the MIM lipid environment represents a novel strategy for treating a wide range of metabolic and degenerative diseases. By preserving the integrity of the MIM lipid environment, these therapies can improve metabolic efficiency and protect against oxidative stress-induced damage in cardiac, neurological, and metabolic diseases.
Drugs such as elamipretide (SS-31) penetrate the outer mitochondrial membrane and bind selectively to cardiolipin within the mitochondrial inner membrane lipid environment. This binding stabilizes cardiolipin molecules, preventing their conversion into pro-apoptotic signaling factors and inhibiting the peroxidase activity of the cytochrome c-cardiolipin complex (Szeto, 2014). This stabilization preserves the curvature of the cristae and the assembly of respiratory supercomplexes, thereby optimizing ATP production and reducing electron leakage that leads to oxidative stress (Birk et al., 2013).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial inner membrane lipid environment.